Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sage Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 12.5K | Jun 10, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SAGE | Sage Therapeutics, Inc. | Jun 10, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
SAGE | Sage Therapeutics, Inc. | Jan 3, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
SAGE | Sage Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
SAGE | Sage Therapeutics, Inc. | Mar 16, 2023 | 1 | $0 | 4 | Mar 17, 2023 | Director |
SAGE | Sage Therapeutics, Inc. | Mar 15, 2023 | 0 | $0 | 3 | Mar 17, 2023 | Director |